ArticleCancers2026
Conversion Surgery for Advanced Gastric Cancer According to First-Line Treatment Strategy: A Single-Center Experience with a Focused Review of the Literature.
Jun Kinoshita, Kenta Doden, Kengo Hayashi, Ryota Matsui, Hiroto Saito, Megumi Watanabe, Toshikatsu Tsuji, Daisuke Yamamoto, Noriyuki Inaki
Abstract read
In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jun KinoshitaDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.ORCID 0000-0002-2871-9549 Kenta DodenDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.
Kengo HayashiDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.
Ryota MatsuiDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.ORCID 0000-0003-0541-2357 Hiroto SaitoDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.
Megumi WatanabeDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.
Toshikatsu TsujiDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.
Daisuke YamamotoDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.ORCID 0000-0002-3539-7728 Noriyuki InakiDepartment of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-Machi, Kanazawa 920-8641, Ishikawa, Japan.ORCID 0000-0002-4241-5015 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
conversion surgerygastric cancerimmune checkpoint inhibitoroligometastasispathological responseprecision medicineprognostic factorstrastuzumab
Identifiers
PMID42588700
PMCPMC13465276
What OpenQuestion holds
Textmetadata
Read underepoch 390